医学
肺动脉高压
药品
肺动脉压
重症监护医学
心脏病学
内科学
药理学
作者
Ramón Limón Ramírez,S. Pienkos,Vinicio de Jesús Pérez,Roham T. Zamanian
标识
DOI:10.1016/j.ccm.2020.11.008
摘要
Pulmonary arterial hypertension secondary to drugs and toxins is an important subgroup of group 1 pulmonary hypertension associated with significant morbidity and mortality. Many drugs and toxins have emerged as risk factors for pulmonary arterial hypertension, which include anorexigens, illicit agents, and several US Food and Drug Administration–approved therapeutic medications. Drugs and toxins are classified as possible or definite risk factors for pulmonary arterial hypertension. This article reviews agents that have been implicated in the development of pulmonary arterial hypertension, their pathologic mechanisms, and methods to prevent the next deadly outbreak of drug- and toxin-induced pulmonary arterial hypertension.
科研通智能强力驱动
Strongly Powered by AbleSci AI